BioPET
Biomarker Prognostic Enrichment Tool
Prognostic Enrichment is a clinical trial strategy of evaluating an intervention in a patient population with a higher rate of the unwanted event than the broader patient population (R. Temple (2010) <DOI:10.1038/clpt.2010.233>). A higher event rate translates to a lower sample size for the clinical trial, which can have both practical and ethical advantages. This package is a tool to help evaluate biomarkers for prognostic enrichment of clinical trials.
Versions across snapshots
| Version | Repository | File | Size |
|---|---|---|---|
0.2.2 |
2026-04-09 windows/windows R-4.5 | BioPET_0.2.2.zip |
78.2 KiB |